TARG Insider Trading Activity and SEC Form 4 Filings
TARG insider trading summary
No open-market insider purchases or sales of Targanta Therapeutics Corp. (TARG) have been reported on SEC Form 4 in the past 12 months.
Latest TARG insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 15, 2007 | Domenic J Ferrante | 10% Owner | Buy | $5.8M (575,000 @ $10.00) |
| Oct 15, 2007 | Brookside Capital Management LLC | 10% Owner | Buy | $5.8M (575,000 @ $10.00) |
| Oct 15, 2007 | Brookside Capital Investors L P | 10% Owner | Buy | $5.8M (575,000 @ $10.00) |
| Oct 15, 2007 | Brookside Capital Partners Fund LP | 10% Owner | Buy | $5.8M (575,000 @ $10.00) |
| Oct 15, 2007 | Eric M Gordon | Director | Buy | $24K (2,429 @ $10.00) |
| Oct 15, 2007 | Jay Venkatesan | Director | Buy | $5.8M (575,000 @ $10.00) |
| Oct 15, 2007 | Eric M Gordon | Director | Buy | $3.0M (300,000 @ $10.00) |
| Oct 15, 2007 | Eric M Gordon | Director | Buy | $976K (97,571 @ $10.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.